Mondrian Investment Partners LTD Pfizer Inc Transaction History

Mondrian Investment Partners LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 17, 2019	SELL	$37.5 - $41.2 $22.3 Million - $24.5 Million	-594,620 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $28.1 Million - $32.1 Million	-731,495 Reduced 55.16%	594,620 $26 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $37.9 Million - $46 Million	-1,099,393 Reduced 45.33%	1,326,115 $58.4 Million
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $230,695 - $245,944	-6,995 Reduced 0.29%	2,425,508 $88 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $10.7 Million - $12.4 Million	-335,552 Reduced 12.12%	2,432,503 $89.1 Million
Q4 2017 Jan 18, 2018	SELL	$33.26 - $35.29 $8.55 Million - $9.08 Million	-257,156 Reduced 8.5%	2,768,055 $100 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $93.8 Million - $103 Million	3,025,211	3,025,211 $108 Million

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Mondrian Investment Partners LTD with notifications on news.